-
Cadent announces FDA Clearance of IND of CAD-9303 for Schizophrenia
- March 11, 2020
- Posted by: PharmaScroll
- Category:
No Comments -
FDA Approves Perseris (risperidone) for Schizophrenia treatment in Adults
- August 6, 2018
- Posted by: PharmaScroll
- Category:
-
FDA Approves new Initiation drug, ARISTADA INITIO, for Schizophrenia
- July 3, 2018
- Posted by: PharmaScroll
- Category:
-
Rxulti (brexpiprazole) for Schizophrenia gets positive CHMP opinion by EMA
- June 3, 2018
- Posted by: PharmaScroll
- Category:
-
Recent study identified Brain cells underlying Schizophrenia
- May 23, 2018
- Posted by: PharmaScroll
- Category:
-
Alkermes to Present Clinical Data related to Schizophrenia and Depression at American Psychiatric Association Annual Meeting
- May 2, 2018
- Posted by: PharmaScroll
- Category:
-
Schizophrenia drug ALKS 3831 completes Patient enrollment in a pivotal study
- April 27, 2018
- Posted by: PharmaScroll
- Category: